Quantcast
Last updated on April 21, 2014 at 1:20 EDT

Latest National Cancer Institute Stories

2013-08-20 09:44:25

For the two-thirds of lung cancer patients with locally advanced or metastatic disease, tumor size is not used currently to predict overall survival times. A new study, however, led by UT Southwestern Medical Center researchers has shown that even in advanced stages total tumor size can have a major impact on survival. Using data from a National Cancer Institute-sponsored Phase 3 trial involving 850 patients with advanced lung cancer, Dr. David Gerber, assistant professor of internal...

2013-08-16 10:15:47

People who reported dietary intake that was most consistent with the 2005 Dietary Guidelines for Americans had lower risk of pancreatic cancer, according to a new study published August 15 in the Journal of the National Cancer Institute. Previous studies investigating the relationship between food and nutrient intake and pancreatic cancer have yielded inconsistent results. The U.S. Government issues evidence-based dietary guidelines that provide the basis for federal nutrition policy and...

2013-08-08 14:13:44

Findings could help identify patients most likely to benefit from lung-sparing surgery A new study by thoracic surgeons and pathologists at Memorial Sloan-Kettering Cancer Center shows that a specific pattern found in the tumor pathology of some lung cancer patients is a strong predictor of recurrence. Knowing that this feature exists in a tumor's pathology could be an important factor doctors use to guide cancer treatment decisions. According to the study's authors, the findings offer...

2013-08-01 23:22:36

The CAI prioritized the NCI portfolio resulting in 50 near-term commercially viable inventions. The CAI will coordinate with small businesses, the biopharmaceutical industry and educational institutions to match these NCI technologies for possible collaboration and technology transfer. Bethesda, Maryland (PRWEB) August 01, 2013 The Center for Advancing Innovation, INC (CAI), a globally focused private-public partnership with an over-arching mission to drive successful innovation entered...

2013-07-31 16:27:15

- Marks the third Phase I STTR award received by Arisaph BOSTON, July 31, 2013 /PRNewswire/ -- Arisaph Pharmaceuticals, Inc., a privately held drug discovery and development biopharmaceutical company focused on developing novel therapies for cardiometabolic diseases and cancer, announced today that it has been awarded a Phase I Small Business Technology Transfer (STTR) award from the National Cancer Institute of the National Institutes of Health. The Phase 1 award supports the...

2013-07-29 10:49:47

Stable survival rates were observed for HIV-associated lymphoma patients during the antiretroviral therapy (ART) era in the US, according to a new study published July 26 in the Journal of the National Cancer Institute. Studies have shown that HIV infection increases the risk of non-Hodgkin lymphoma (NHL) and Hodgkin lymphoma (HL) and that incidence for many lymphoma types has not decreased in the ART era. Furthermore, lymphoma is the most frequent cancer-related cause of death among...

2013-07-18 10:27:16

In patients with high-risk breast cancer, addition of the erythropoiesis-stimulating agent (ESA) epoetin alfa to the chemotherapy regimen may help avoid the decrease in hemoglobin levels and resulting anemia often seen in these patients and does not negatively affect relapse-free (RFS) or overall survival (OS). However, it can increase the risk of thrombotic events, according to a study published July 17 in the Journal of the National Cancer Institute. To investigate the safety and...

2013-07-12 23:24:20

Diindolylmethane (DIM) from broccoli slows down the aging process, boosts the immune system, and brings new hope to the fight against cancer. Diindolylmethane (DIM) News Update from the Diindolylmethane (DIM) Information Resource Center (http://www.diindolylmethane.org/) Berkeley, CA (PRWEB) July 11, 2013 With all of the media enthusiasm in Washington regarding President Obama’s recent comment about broccoli being his favorite food, it is timely to bring an important and recent...

2013-07-08 08:26:44

By the National Cancer Institute BETHESDA, Md., July 8, 2013 /PRNewswire-USNewswire/ --When NFL Hall of Famer Gene Upshaw died of pancreatic cancer in 2008, it was the first time that many Americans had heard of the disease. Like many patients with this deadly cancer, the 63-year-old Upshaw died a short period after his diagnosis, shocking many football fans. The news of his death also shone a spotlight on a disease that, although rare, disproportionately affects African Americans....

2013-07-01 11:26:29

Elevated HOXB13/IL17BR ratio may indicate who should receive extended treatment with letrozole A biomarker reflecting expression levels of two genes in tumor tissue may be able to predict which women treated for estrogen-receptor (ER)-positive breast cancer should receive a second estrogen-blocking medication after completing tamoxifen treatment. In their report being published online in the Journal of the National Cancer Institute, Massachusetts General Hospital (MGH) Cancer Center...